| AGE | Advanced glycation end products |
| AMP | Antimicrobial peptide |
| BCL6 | B-cell lymphoma-6 protein |
| DNA | Deoxyribonucleic acid |
| ECM | Extracellular matrix |
| EMA | European Medicines Agency |
| FDA | US Food and Drug Administration |
| GRAS | Generally recognized as safe |
| HA | Hyaluronic acid |
| HCA2 | Hydroxycarboxylic acid receptor 2 |
| IL | Interleukins |
| MHC | Major histocompatibility complex |
| MMP | Matrix metalloproteinases |
| MRC-1 | Mannose receptor C-1 |
| mRNA | Messenger ribonucleic acid |
| NAD+ | Nicotinamide adenine dinucleotide (oxidized) |
| NADH | Nicotinamide adenine dinucleotide (reduced) |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| PARP | Poly-(ADP-ribose) polymerase |
| PGE2 | Prostaglandin E2 |
| ROS | Reactive oxygen species |
| SASP | Senescence-associated secretory phenotype |
| SIRT | Sirtuin |
| TNF-α Tumour necrosis factor alpha | |
| US | United States of America |
| UV | Ultraviolet |